Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Kimberly H. Johnson, a director at Eli Lilly & Co, acquired 12,409 shares of common stock through a deferral plan.

Summary

• Kimberly H. Johnson, a director at Eli Lilly & Co, acquired 12,409 shares of common stock on December 16, 2024.
• The shares were acquired through the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• These shares will be settled in common stock after Ms. Johnson's separation from service.
• Following the transaction, Ms. Johnson directly owns 3,032.146 shares of Eli Lilly common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, indicating a positive alignment of director interests with the company's long-term performance. It is not a major event but is a positive sign.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The use of a deferral plan aligns the director's interests with long-term shareholder value.

Future Outlook

The acquired shares will be settled in common stock following the director's separation from service.

Industry Context

This is a routine transaction for directors of publicly traded companies, often part of their compensation packages and long-term incentive plans.

Comparison to Industry Standards

• Director share acquisitions through deferral plans are common practice among large publicly traded companies, including pharmaceutical companies like Pfizer (PFE) and Merck (MRK).
• These plans are designed to align the interests of directors with the long-term performance of the company, similar to stock option grants and restricted stock units.
• The number of shares acquired is typical for a director's compensation package, and the deferral mechanism is a standard approach to incentivize long-term commitment.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it demonstrates director confidence in the company.
• The deferral plan aligns the director's interests with long-term shareholder value.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Stock Units, Form 4, LLY